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Abstract
How the cerebellum carries out its functions is not clear, even for its established roles in motor control. In particular, little 
is known about how the cerebellar nuclei (CN) integrate their synaptic and neuromodulatory inputs to generate cerebellar 
output. CN neurons receive inhibitory inputs from Purkinje cells, excitatory inputs from mossy fibre and climbing fibre col-
laterals, as well as a variety of neuromodulatory inputs, including cholinergic inputs. In this study we tested how activation 
of acetylcholine receptors modulated firing rate, intrinsic properties and synaptic transmission in the CN. Using in vitro 
whole-cell patch clamp recordings from neurons in the interpositus nucleus, the acetylcholine receptor agonist carbachol 
was shown to induce a short-term increase in firing rate, increase holding current and decrease input resistance of interposi-
tus CN neurons. Carbachol also induced long-term depression of evoked inhibitory postsynaptic currents and a short-term 
depression of evoked excitatory postsynaptic currents. All effects were shown to be dependent upon muscarinic acetylcholine 
receptor activation. Overall, the present study has identified muscarinic receptor activation as a modulator of CN activity.
Keywords Cerebellar nuclei · Acetylcholine · Muscarinic receptors · Carbachol
Introduction
The cerebellum, a structure containing approximately 80% 
of neurons in the human brain [1], has well-established roles 
in motor functions including coordination, balance, postural 
control, the accurate execution of fine movements, and in 
association with such roles it is central to motor learning [2, 
3]. The cerebellum has also been linked to a number of non-
motor functions, including cognitive planning [4], spatial 
representation [5], fear responses [6], sensory processing 
[7], language [8] and attention [9]. This wide range of func-
tions is likely due to connections—either direct or indirect—
with a wealth of brain regions including, but not limited to, 
the motor cortex [10], basal ganglia [11], prefrontal cortex 
[12–14] and hippocampus [15, 16].
The cerebellar nuclei (CN) contain the final output neu-
rons of the cerebellum. CN neurons receive excitatory col-
lateral inputs from mossy fibres and climbing fibres, the two 
major synaptic inputs to the cerebellum, as well as inhibitory 
inputs from Purkinje cells, which form the sole output of the 
cerebellar cortex. In addition, there are several neuromodu-
latory inputs which project with varying patterns throughout 
the cerebellar cortex and CN. Despite early evidence for 
roles of the cholinergic system in modulating CN activity 
[e.g. 17] and extensive studies on this system in other brain 
regions, little is known about the roles of acetylcholine in 
the cerebellum.
Anatomical studies have demonstrated the presence of 
a set of varicose, beaded choline acetyltransferase (ChAT) 
positive fibres which form a diffuse network throughout 
the cerebellar cortex and CN [18]. Double labelling studies 
combining retrograde labelling and ChAT immunostaining 
have demonstrated these fibres arise from the pedunculo-
pontine nucleus (PPN), laterodorsal tegmental nucleus and 
other brainstem nuclei including the lateral paragiganto-
cellular nucleus, nucleus raphe obscurus, the vestibular 
nuclei and the pars interpolaris of the spinal trigeminal 
complex [18, 19]. The cholinergic influence arising from 
the PPN has recently been demonstrated physiologically 
in the CN, whereby electrical stimulation of the PPN pro-
duced a short latency (1.5–2 ms, implying a direct con-
nection) orthodromic response in CN neurons which was 
blocked by acetylcholine receptor antagonists [20]. Whilst 
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little is known about the functional role(s) of this projec-
tion it is suggested to be involved in sleep–wake cycle reg-
ulation as well as motor functions. Therefore, cholinergic 
inputs to the cerebellum may be involved in modulating 
intrinsic properties and synaptic inputs of CN neurons to 
mediate cerebellar activity in different behavioural states.
The cerebellum is a key player in motor learning with 
synaptic plasticity in cerebellar circuits, including the CN, 
thought to underlie the storage of information [21, 22]. As 
such, long-term synaptic plasticity has been demonstrated 
at both inhibitory inputs [23, 24] and excitatory inputs 
to CN neurons [25, 26]. The importance of acetylcholine 
receptors for learning and memory and its underlying 
synaptic plasticity mechanisms has been demonstrated in 
many brain regions both in vitro and in vivo [e.g. 27–29]. 
Similarly, in the cerebellum cholinergic receptor activa-
tion can modulate long-term potentiation at parallel fibre 
inputs to Purkinje cells in the cerebellar cortex [30], but 
nothing is known about how acetylcholine modulates plas-
ticity within the CN. Acetylcholine may act to modulate 
neuronal activity and plasticity of synapses within CN, 
and through these mechanisms contribute to cerebellar 
function and learning. For example, in humans, systemic 
administration of the muscarinic acetylcholine receptor 
antagonist scopolamine impairs acquisition of cerebellar-
dependent classical eyeblink conditioning [31, 32].
To study the effects of cholinergic receptor activation 
on synaptic and intrinsic properties of CN neurons, whole-
cell patch clamp recordings were performed from inter-
positus nucleus neurons in rat cerebellar slices. The results 
provide evidence for a role of muscarinic acetylcholine 
receptors in mediating a number of effects in CN neurons. 
The modulatory influence on CN neurons, in turn, could 
alter their control of downstream brain regions and there-
fore impact cerebellar-mediated behaviours, including 




All experiments were carried out in accordance with the 
UK Animals (Scientific Procedures) Act of 1986 and 
approved by the University of Bristol Animal Welfare and 
Ethical Review Body.
Male Wistar rats aged postnatal day 13–15 were 
obtained from breeding stocks at the University of Bristol. 
Animals were housed on a 12/12 h light/dark cycle (lights 
on at 8 a.m.) with the mother and littermates.
Slice Preparation
Rats were deeply anaesthetised with isoflurane and decapi-
tated. The cerebellum was rapidly removed and placed 
into ice cold (2–4 °C) sucrose cutting solution, containing 
(in mM): 189 sucrose, 10 d-glucose, 26  NaHCO3, 3 KCl, 
5  MgSO4·7H2O, 0.1  CaCl2, 1.25  NaH2PO4, equilibrated 
with 95%  O2/5%  CO2. Coronal sections (400 µm thickness) 
containing the CN were prepared using ceramic blades on 
a vibrating microtome (7000smz, Campden Instruments, 
Loughborough). For the first 30 min following slicing, slices 
were kept in artificial cerebrospinal fluid (ACSF) containing 
(in mM): 124 NaCl, 26  NaHCO3, 3 KCl, 1.4  NaH2PO4, 1 
 MgSO4·7H2O, 10 d-glucose and 2  CaCl2 (equilibrated with 
95%  O2/5%  CO2) at approximately 35 °C, and then at room 
temperature for at least another 30 min before recording. 
Following incubation slices were bisected along the midline.
Whole Cell Recordings
Slices were placed in a submerged chamber and continu-
ously perfused with ACSF at a rate of approximately 2 ml/
min. Bath temperature was maintained at 32 ± 1 °C. Whole 
cell patch clamp recordings were made from neurons of 
the interpositus nucleus identified on an upright micro-
scope (Eclipse E600 FN, Nikon Instruments) using a 40× 
water immersion objective and infrared differential inter-
ference contrast optics. The CN were identified based on 
their shape and location within the white matter, and large 
cells, corresponding to large glutamatergic projection neu-
rons (soma > 20 µm), were targeted for recording [33].
Recordings were made using pipettes (2–5 MΩ) pulled 
from borosilicate glass capillaries on a horizontal puller 
(P-97, Sutter Instrument). Pipettes were filled with caesium-
based internal solution for voltage clamp recordings (con-
taining (in mM): 130  CsMeSO4, 10 HEPES, 0.5 EGTA, 4 
MgATP, 0.3 NaGTP, 5 QX-314-Cl−, and 8 NaCl, titrated 
to pH 7.25 using CsOH, osmolarity 280–290 mOsM) and 
potassium-based solution for current clamp recordings (con-
taining (in mM): 145 K-gluconate, 5 NaCl, 10 HEPES, 0.2 
EGTA, 0.3 NaGTP and 4 MgATP, titrated to pH 7.25 using 
KOH, osmolarity 280–290 mOsM). Recording electrodes 
were placed in contact with the soma of a target neuron and 
after forming a tight seal (> 1 GΩ) negative pressure was 
applied using suction to achieve the whole cell configuration.
Spontaneous action potentials were recorded in cur-
rent clamp configuration at resting potential (no current 
injection). In current clamp experiments, recordings com-
menced after obtaining whole cell configuration and com-




Postsynaptic responses were evoked using a concentric 
bipolar stimulating electrode (FHC) placed in the white 
matter adjacent to the interpositus nucleus. Constant 
current pulses of 0.1 ms were delivered using a constant 
current isolated stimulator (DS3, Digitimer). Inhibitory 
GABAergic responses were examined during pharmaco-
logical blockade of excitatory transmission, by adding the 
AMPA receptor antagonist NBQX (5 µM) and the NMDA 
receptor antagonist D-AP5 (50 µM) to the ACSF. Excita-
tory glutamatergic responses were examined during phar-
macological blockade of GABAergic transmission, by add-
ing the  GABAA receptor antagonist picrotoxin (50 µM) to 
the ACSF. After obtaining stable response amplitude for 
at least 10 min, compounds were bath applied in the ACSF 
as specified in the “Results” section.
In voltage clamp recordings cells were held at − 50 mV 
for both inhibitory postsynaptic current (IPSC) and excita-
tory postsynaptic current (EPSC) recordings. Series resist-
ance and input resistance were monitored at 30 s intervals 
throughout voltage clamp experiments by use of a 5 mV 
hyperpolarising step; data were discarded if series resist-
ance deviated more than 20% from baseline. Data were 
acquired using an Axopatch 200B amplifier (Molecular 
Devices) and WinLTP software, filtered at 5 kHz and digit-
ised at a sampling rate of 20 kHz for voltage clamp record-
ings and 40 kHz for current clamp recordings (Digidata 
1322A, Molecular Devices). No correction was applied to 
compensate for liquid junction potential.
Data Analysis
WinLTP [v1.10, 34] was used for online assessment of 
evoked response amplitude and monitoring series and 
input resistance of cells, and WinLTP reanalysis software 
was used for post-hoc experimental measurements. Spon-
taneous firing rate was analysed post-hoc using Spike2 
(v7.12, CED). For spontaneous firing experiments data 
are plotted as z-score firing rate over time (firing rates for 
individual cells z-scored and then averaged, mean ± SEM). 
The difference between firing rate and membrane poten-
tial at 4–5 min following the start of drug application and 
baseline (the minute before drug application, to allow 
stabilisation of firing rate and membrane potential with 
dialysis of the internal solution) was calculated. Therefore, 
in these experiments a difference of 0 corresponds to no 
change in firing rate. Voltage clamp data are expressed as 
the mean ± SEM and are normalised to baseline values, 
with a baseline average of 1. To account for any antagonist 
effects baseline was the 10-min period preceding carba-
chol application. Graphs were produced using SigmaPlot 
(Windows Version 13.0).
Statistics
All statistical analyses were performed using SPSS statistics 
software, as stated in the “Results” section. Spontaneous 
firing frequencies were analysed using the Wilcoxon singed 
ranks test (as data were not normally distributed) using raw 
firing rates before and during drug application. In voltage 
clamp experiments, measurements of holding current, input 
resistance and postsynaptic current amplitude during base-
line were compared with the same measures at a set time 
point following drug application, as stated in the appropriate 
“Results” section, and tested for statistical significance using 
a two-tailed paired t-test of average values (before normali-
sation). Between group differences were assessed using a 
one-way ANOVA performed on normalised values.
Results
Cholinergic Receptor Modulation of Firing Rate
We first investigated the effect of a cholinergic agonist on 
CN neuron firing rates. Bath application of the cholinomi-
metic compound carbachol (10 µM) increased the firing 
rate of CN neurons from 4.13 ± 1.07 Hz to 8.54 ± 1.84 Hz 
(1.87 ± 0.63 difference in z-score firing rate at 4–5 min 
into carbachol application compared to the minute before 
carbachol; Fig.  1a, n = 9, Wilcoxon signed ranks test: 
z = − 2.100, p = 0.036). The coefficient of variance of the 
inter-spike time interval (CV) was 0.17 ± 0.05 during base-
line and 0.62 ± 0.41 during carbachol application (Wilcoxon 
signed ranks test: Z = − 0.315, p = 0.752), and the CV2 was 
0.09 ± 0.02 during baseline and 0.15 ± 0.05 during carba-
chol application (Wilcoxon signed ranks test: Z = − 0.943, 
p = 0.345).
To investigate the receptor subtypes involved in the 
carbachol-induced increase in firing rate, carbachol was 
co-applied with the broad-spectrum muscarinic receptor 
antagonist scopolamine (10 µM). The carbachol-induced 
increase in firing rate was blocked in the presence of sco-
polamine (0.13 ± 0.13 difference in z-score firing rate; 
Fig. 1c, n = 7, Wilcoxon signed ranks test: Z = − 1.069, 
p = 0.285). To test if there was any tonic activation of mus-
carinic receptors in the slice preparation, scopolamine was 
applied in the absence of carbachol. Scopolamine alone had 
no effect on firing rate (− 0.05 ± 0.34 difference in z-score 
firing rate, Fig.  1c, n = 8, Wilcoxon signed ranks test: 
Z = − 0.420, p = 0.674). The change in firing rate following 
carbachol was significantly different to both co-application 
with scopolamine and scopolamine alone (Fig. 1c, one-way 
ANOVA on difference in z-score with Tukey’s HSD post-
hoc: F(2,21) = 5.557, p = 0.012; carbachol versus carbachol 
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with scopolamine p = 0.040, carbachol versus scopolamine 
alone p = 0.017).
The membrane potential was depolarised in response 
to carbachol by an average of 7.31 ± 1.42 mV when com-
paring the minute before application to 4–5 min following 
the start of application (Fig. 1d, from − 51.19 ± 1.89 mV 
to − 43.88 ± 1.88 mV, n = 9, paired t-test: t(8) = − 5.153, 
p = 0.001). Co-application of scopolamine with carbachol 
reduced the difference in membrane potential following 
carbachol application to 4.36 ± 0.95, although a statistically 
significant increase still occurred (Fig. 1d, n = 7, paired t-test 
t(6) = − 4.608, p = 0.004). Scopolamine alone had no signifi-
cant effect on membrane potential of CN neurons (Fig. 1d, 
2.08 ± 0.99 mV, n = 8, paired t-test t(7) = − 2.096, p = 0.074).
Previous experiments have shown that activation of cho-
linergic receptors can increase CN firing rates in vivo [e.g. 
17]. Our results show that acetylcholine receptors control 
firing rates in vitro in the absence of ongoing sensory inputs 
that would be present in vivo. Importantly, we show that 
the carbachol-induced increase in firing rate depends upon 
the activation of muscarinic acetylcholine receptors (sum-
marised in Fig. 1c).
Cholinergic Receptor Modulation of Holding Current 
and Membrane Resistance in Voltage Clamp
Carbachol (10 µM) application produced an increase in 
the holding current required to voltage clamp neurons at 
− 50 mV (1.21 ± 0.07 during the last 10 min of carbachol 
application relative to baseline, Fig. 2ai; n = 15; paired t-test: 
t(14) = 3.153, p = 0.007). The holding current was not sig-
nificantly different when carbachol was co-applied with 
scopolamine (10 µM, 1.14 ± 0.07 relative to 10 min period 
prior to carbachol application; Fig. 2aii, n = 12, paired t-test: 
t(11) = 0.988, p = 0.344). The carbachol-induced changes in 
holding current were reduced when the  M1 selective antag-
onist VU0255035 was co-applied with carbachol, and the 
increase was no longer statistically significant (1.16 ± 0.06, 
Fig. 2aiii, n = 9, paired t-test: t(8) = 1.726, p = 0.123). A 
summary of the effects on holding current during the last 
10 min of carbachol application relative to baseline is shown 
in Fig. 2aiv.
A decrease in input resistance occurred with carba-
chol application (0.85 ± 0.03 relative to baseline; Fig. 2bi; 
n = 15, paired t-test: t(14) = 5.298, p = < 0.001) but this was 
inhibited when carbachol was co-applied with scopolamine 
(0.93 ± 0.06; Fig. 2bii, n = 12, paired t-test: t(11) = 1.644, 
p = 0.129). There was also no significant change in input 
resistance when VU0255035 was co-applied with carba-
chol (0.98 ± 0.05, Fig. 2biii, n = 9, paired t-test: t(8) = 0.304, 
p = 0.769). The results summarised in Fig. 2aiv Fig. 2biv 
show that muscarinic receptors, including  M1 receptors, con-
tribute to carbachol-induced changes in membrane potential 
and input resistance.
Cholinergic Receptor Modulation of Postsynaptic 
Currents
The white matter surrounding the CN comprises a com-
bination of inhibitory GABAergic Purkinje cell axons 
and excitatory glutamatergic mossy fibres and climbing 
fibres. Under control conditions electrical stimulation of 
the white matter resulted in both inhibitory and excitatory 
postsynaptic responses of a similar latency in interposi-
tus neurons recorded in voltage clamp. In the following 
experiments inhibitory and excitatory components were 
Fig. 1  Effects of cholinergic receptor activation on the spontaneous 
firing rates and membrane potential of interpositus neurons in slices. 
a Bath application of carbachol increased the firing rate of interposi-
tus neurons during whole cell recordings (n = 9). b Example experi-
ment showing membrane depolarisation and increased firing rate in 
response to carbachol application. c Summary of difference in fir-
ing rate 4–5  min after the start of carbachol application, relative to 
pre-drug firing levels (compared using Wilcoxon signed rank test, 
*p < 0.05). The carbachol-induced increase in firing was blocked by 
scopolamine (n = 7) and scopolamine alone had no effect on firing 
rate (n = 8). d Change in membrane potential relative to pre-drug for 
the three conditions. Carbachol alone and carbachol with scopola-
mine significantly increased the membrane potential, but scopolamine 
alone had no significant effect (paired t-test **p < 0.01). Groups in c 




studied individually following their pharmacological isola-
tion (Fig. 3a). Inhibitory responses were isolated through 
bath application of the AMPA receptor antagonist NBQX 
(5 µM) and the NMDA receptor antagonist D-AP5 (50 µM, 
Fig. 3ai). Excitatory responses were isolated through bath 
application of the  GABAA receptor antagonist picrotoxin 
(50 µM, Fig. 3aii). Combined application of NBQX, D-AP5 
and picrotoxin blocked all postsynaptic currents (Fig. 3aiii).
To investigate effects of cholinergic receptor activation 
on inhibitory synaptic inputs to the interpositus nucleus, 
carbachol was applied to the slice during IPSC recordings. 
Bath application of carbachol (10 µM) for 20 min decreased 
the average amplitude of IPSCs to 0.67 ± 0.10 relative to the 
baseline in the 10 min following the end of drug applica-
tion (Fig. 3bi, n = 8, paired t-test: t(7) = 3.619, p = 0.009). 
This depression did not recover during the remainder of the 
recording period (repeated measures ANOVA comparing 
baseline to 10 min following end of carbachol application to 
40–50 min time point: F(2,12) = 6.690, p = 0.011; baseline 
vs 40–50 min p = 0.046).
Scopolamine (10 µM) was bath applied before and dur-
ing carbachol application (Fig. 3bii). In the 10 min follow-
ing the end of drug application scopolamine reduced the 
effect of carbachol (average response 0.87 ± 0.10 compared 
to 10  min period prior to carbachol application, n = 6, 
paired t-test: t(5) = 1.171, p = 0.294). These data show that 
the carbachol-mediated depression involved activation of 
muscarinic acetylcholine receptors. To further investigate 
the muscarinic receptors involved, the  M1 receptor specific 
antagonist VU0255035 (10 µM) was used. VU0255035 also 
reduced the effects of carbachol (0.87 ± 0.11 in the 10 min 
following the end of carbachol application; Fig. 3biii, n = 5, 
paired t-test: t(4) = 1.148, p = 0.315). The results, summa-
rised in Fig. 3biv, show that although some changes in IPSC 
amplitude occurred in the presence of these antagonists, the 
effects of carbachol were reduced and therefore the depres-
sion observed in response to carbachol application is at least 
partly dependent upon  M1 muscarinic receptor activation.
Carbachol was also applied to slices during EPSC record-
ings to investigate the effects of cholinergic receptor activa-
tion on excitatory synaptic inputs to the interpositus nucleus. 
Bath application of carbachol (10 µM) for 20 min decreased 
the amplitude of EPSCs, with peak depression occurring 
during the last 10 min of drug application (Fig. 3ci, n = 7). 
The average normalised response during this period was 
0.54 ± 0.06 relative to baseline (paired t-test: t(6) = − 7.365, 
p < 0.001). A one-way repeated measures ANOVA compar-
ing response amplitude during baseline, the last 10 min of 
drug application (peak depression), and post-drug appli-
cation (40–50 min, to test long-term effects) showed a 
Fig. 2  Acetylcholine receptor activation depolarised interpositus 
neurons and caused a decrease in input resistance. a (i) Carbachol 
application produced an increase in holding current required to volt-
age clamp interpositus neurons (n = 15) that was not significant in 
the presence of (ii) scopolamine (n = 12) or (iii) VU0255035 (n = 9). 
(iv) The average normalised current required to maintain membrane 
potential at − 50 mV in the last 10 min of carbachol application com-
pared to the 10 min prior to carbachol application. b (i) Input resist-
ance (Rm) of interpositus neurons decreased in response to carbachol 
application (n = 15). This effect was reduced by (ii) scopolamine 
(n = 12) or (iii) VU0255035 (n = 9). (iv) The average normalised 
input resistance in the last 10 min of carbachol application compared 
to the 10 min prior to carbachol application. *p < 0.01, paired t-test 




significant difference between baseline and the last 10 min 
of drug application, but not between baseline and the post-
drug time point, showing that the effect was not long-lasting 
(test of within subject effects: F(2,12) = 5.129, p = 0.025; 
baseline vs. last 10 min of drug application mean differ-
ence = − 136.82, p = 0.001; other pairwise comparisons not 
significant; Bonferroni correction applied).
Scopolamine was bath applied prior to co-application 
of carbachol and inhibited the carbachol induced depres-
sion of EPSC amplitude (Fig. 3cii); in the last 10 min of 
carbachol application the average response was 0.93 ± 0.05 
(n = 6, paired t-test: t(5) = − 1.342, p = 0.237). Similarly, co-
application of VU0255035 reduced the effects of carbachol 
(0.91 ± 0.02) although a statistically significant depression 
compared to baseline was still observed (Fig. 3ciii, n = 4, 
paired t-test: t(3) = − 3.913, p = 0.030). The EPSC ampli-
tude during the last 10 min of carbachol application was 
significantly different to that during either scopolamine or 
VU0255035 co-application (Fig. 3civ, one-way ANOVA 
with Tukey’s HSD post-hoc: F(2,14) = 16.545, p < 0.001; 
carbachol vs. carbachol with scopolamine p < 0.001; car-
bachol vs. carbachol with VU0255035 p = 0.002). This 
suggests that  M1 muscarinic receptors are involved in carba-
chol-induced depression at excitatory inputs to CN neurons.
Discussion
Our results demonstrate that muscarinic receptor activa-
tion in cerebellar slices contributes to several effects in 
CN neurons, including: (i) a brief increase in firing rate; 
(ii) a decrease in input resistance; (iii) long-term depres-
sion of inhibitory synaptic responses; and (iv) a shorter-
term depression of excitatory synaptic responses. Most of 
these effects were reduced, although not always completely 
blocked, by either the broad-spectrum muscarinic antago-
nist scopolamine or the specific  M1 antagonist VU0255035 
(Fig. 2). This suggests that other receptors, such as nicotinic 
acetylcholine receptors, may be involved in mediating the 
full extent of carbachol-induced changes in CN neurons.
Following carbachol application the enhanced firing rate 
returned over time to baseline levels (Fig. 1). In the example 
neuron shown in Fig. 1b, carbachol induced a depolarisa-
tion of the neuron accompanied by action potential firing; as 
Fig. 3  Effects of cholinergic receptor activation on synaptic responses 
within the interpositus nucleus. a Synaptic responses recorded from 
interpositus neurons following electrical stimulation of the adja-
cent white matter: (i) Example IPSC recorded in the presence of 
NBQX (5  µM) and D-AP5 (50  µM); (ii) Example EPSC recorded 
in the presence of picrotoxin (50  µM); (iii) all components of the 
synaptic response were blocked by the co-application of picrotoxin, 
NBQX and D-AP5. All traces shown are an average of ten consecu-
tive responses; holding potential − 50  mV. b Effects of the follow-
ing cholinergic compounds on inhibitory synaptic responses within 
interpositus neurons were investigated: (i) Carbachol (10 µM, n = 8); 
(ii) the muscarinic antagonist scopolamine co-applied with carbachol 
(10  µM, n = 6); and (iii) the  M1 antagonist VU0255035 co-applied 
with carbachol (10  µM, n = 5); (iv) Average IPSC amplitude in the 
10 min following the end of drug application relative to baseline. c 
Effects of the following compounds on excitatory synaptic responses 
within interpositus neurons were investigated: (i) Carbachol (10 µM, 
n = 7); (ii) scopolamine co-applied with carbachol (10 µM, n = 6); and 
(iii) VU0255025 co-applied with carbachol (10  µM, n = 4); (iv) 
Average EPSC amplitude during the last 10 min of drug application 
relative to baseline. Paired t-test for baseline vs carbachol compari-
son; one-way ANOVA for between groups comparison, *p < 0.05, 
**p < 0.01, ***p < 0.001. Average values normalised to the baseline 
of each experiment are plotted ± SEM. Insets show example traces 
(average of 20 consecutive responses from a 10-min period) displayed 
from the baseline (black) and from selected time-points following 
drug application as indicated in b and c 
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carbachol was washed from the bath the membrane returned 
to a more hyperpolarised potential and firing ceased. The 
pooled data show that on average the firing rate peaked and 
then returned to baseline levels during carbachol applica-
tion (Fig. 1a). It may be that acetylcholine receptors had 
become desensitised to prolonged carbachol application. 
Scopolamine alone did not completely block the carbachol-
induced increase in membrane potential (Fig. 1d), suggest-
ing an involvement of nicotinic receptors which are prone to 
desensitisation following prolonged agonist application [35].
Depolarisation of CN neurons accompanied the observed 
increase in firing rate; carbachol induced a significant change 
in membrane potential of CN neurons in current clamp 
recordings (Fig. 1d). A sustained increase in the amount of 
current required to voltage clamp neurons at − 50 mV was 
also observed (Fig. 2ai), reinforcing the depolarising effects 
of carbachol. The magnitude of this depolarisation was 
reduced in the presence of scopolamine (Fig. 1d). Although 
scopolamine did not block the effects of carbachol on mem-
brane potential—there was still a significant difference 
compared to baseline—the reduction appeared sufficient to 
prevent significant changes in firing, as no change in firing 
rate occurred during co-application of scopolamine with 
carbachol (Fig. 1c). This suggests that additional receptors 
unaffected by scopolamine (i.e. nicotinic receptors) contrib-
ute to the change in membrane potential, but that inhibiting 
muscarinic receptors is enough to prevent changes in firing 
rate in response to carbachol.
Synaptic inputs were not blocked during current clamp 
experiments, and so presynaptic effects of carbachol on the 
effects observed cannot be ruled out based on the current 
data. However, related changes in intrinsic properties were 
seen in voltage clamp experiments (increased holding cur-
rent and decreased membrane resistance, Fig. 2) when syn-
aptic blockers were present, suggesting that at least some 
of the effects of carbachol are mediated postsynaptically. 
Further experiments are needed to determine whether the 
effects of carbachol on synaptic currents (Fig. 3) are medi-
ated through pre- or postsynaptic mechanisms.
The changes to membrane potential and input resist-
ance following carbachol application (Fig. 2) are likely 
due to the modulation of several ionic conductances fol-
lowing muscarinic receptor activation. Muscarinic depo-
larisation typically shows an initial large inward current 
resulting from a decrease in inward potassium current and 
increase in hyperpolarisation-activated cation current Ih 
 (M3 receptor mediated), and a later  M1 receptor mediated 
decrease in inward potassium current [36]. This is usually 
associated with an increased input resistance; however, the 
experiments here displayed a decreased input resistance 
(Fig. 2bi). It has previously been observed in neurons of 
the basolateral complex of the amygdala that carbachol 
induced a depolarisation accompanied by decreased or 
unchanged input resistance, and this effect occurred during 
blockade of the M-current [37]. An alternative conduct-
ance pathway may therefore be related to these effects of 
carbachol, for example a calcium-dependent potassium or 
non-specific cation conductance, which may be similar to 
the present experiments [37, 38].
We observed different temporal profiles of depression 
of inhibitory and excitatory synaptic transmission within 
CN (Fig. 3bi, ci). The inhibitory responses recorded in CN 
neurons (e.g. Fig. 3ai) likely correspond to inputs from 
Purkinje cells. Purkinje cell projections are estimated to 
account for 70% of the innervation of the CN [39], and 
electrical stimulation of the white matter in the presence 
of glutamate receptor antagonists has been shown to gen-
erate a comparable response to that evoked from selective 
optogenetic activation of Purkinje cell axons [40], sug-
gesting minimal contribution from other sources of inhibi-
tory activity. The excitatory responses (e.g. Fig. 3aii) are 
likely to correspond to mossy fibre inputs; a study assess-
ing mossy fibre and climbing fibre inputs to CN in young 
(postnatal day 12–23) mice selectively using optogenetic 
methods concluded that electrical stimulation in slices 
primarily recruits mossy fibre responses, as short term 
depression of EPSCs following repeated electrical stimu-
lation is similar to that following selective mossy fibre 
activation, yet less than following selective climbing fibre 
activation [41, 42].
The relative strength and timing of excitation and inhibi-
tion of CN neurons may be key to information coding and 
storage in the cerebellum; the direction of long-term plastic-
ity at mossy fibre-CN synapses depends on the state of the 
postsynaptic CN neuron [25, 26, 43]. Inhibition driven by 
Purkinje cells guides the strengthening of excitatory syn-
apses to CN neurons by driving their hyperpolarisation, and 
instead causes depression if there is a reduced level of inhi-
bition. The net effect acetylcholine on CN may be to produce 
a short-term increase in CN output that results from a long-
term depression of inhibition (Fig. 3bi) but only short-term 
depression of excitatory inputs (Fig. 3ci). The changes in 
the strength and balance of excitatory and inhibitory inputs 
by acetylcholine receptor activation may therefore influence 
other plasticity mechanisms within the CN, and the result-
ing changes in cerebellar output signals via CN may affect 
downstream brain regions and thus cerebellar-mediated 
behaviours including motor learning.
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